Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-25 Sale | 2022-11-29 5:33 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 3,532 | $2.7196 | $9,606 | 154,621 (Direct) | View |
| 2022-11-25 Sale | 2022-11-29 5:25 pm | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 2,116 | $2.7193 | $5,754 | 87,389 (Direct) | View |
| 2022-08-25 Sale | 2022-08-29 9:18 pm | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 2,190 | $4.0118 | $8,786 | 89,505 (Direct) | View |
| 2022-08-25 Sale | 2022-08-29 9:14 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 3,655 | $4.0162 | $14,679 | 158,153 (Direct) | View |
| 2022-08-25 Sale | 2022-08-29 9:11 pm | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO | 13,379 | $4.0105 | $53,656 | 908,778 (Indirect Direct) | View |
| 2022-05-25 Sale | 2022-05-27 5:34 pm | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO | 13,162 | $1.9011 | $25,022 | 922,157 (Indirect Direct) | View |
| 2022-05-25 Sale | 2022-05-27 5:32 pm | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 2,154 | $1.9011 | $4,095 | 91,695 (Direct) | View |
| 2022-05-25 Sale | 2022-05-27 5:27 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 3,596 | $1.9011 | $6,836 | 161,808 (Direct) | View |
| 2022-02-25 Sale | 2022-03-01 9:13 pm | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO | 14,635 | $2.7795 | $40,678 | 935,319 (Indirect Direct) | View |
| 2022-02-25 Sale | 2022-03-01 9:12 pm | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 2,395 | $2.7795 | $6,657 | 93,849 (Direct) | View |
| 2022-02-25 Sale | 2022-03-01 9:10 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 3,998 | $2.7795 | $11,112 | 165,404 (Direct) | View |
| 2021-11-25 Sale | 2021-11-29 7:50 pm | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 4,541 | $4.8112 | $21,847 | 96,244 (Direct) | View |
| 2021-11-25 Sale | 2021-11-29 7:48 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 7,579 | $4.8112 | $36,464 | 169,402 (Direct) | View |
| 2021-11-25 Sale | 2021-11-29 7:46 pm | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO | 27,747 | $4.8112 | $133,495 | 942,954 (Indirect Direct) | View |
| 2021-11-15 Purchase | 2021-11-15 5:59 pm | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO | 8,000 | $5.56 | $44,480 | 567,198 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-11-25 Exercise | 2022-11-29 5:33 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 6,889 | $0 | 154,621 (Direct) | View |
| 2022-11-25 Exercise | 2022-11-29 5:25 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 4,127 | $0 | 87,389 (Direct) | View |
| 2022-11-25 Exercise | 2022-11-29 5:21 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director | 9,034 | $0 | 144,547 (Direct) | View |
| 2022-11-25 Exercise | 2022-11-29 5:18 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 25,219 | $0 | 908,778 (Direct) | View |
| 2022-09-19 Option Award | 2022-09-19 7:04 pm | N/A 2032-09-19 | Viracta Therapeutics Inc. | VIRX | Rothera Mark CEO | 1,375,000 | $0 | 1,375,000 (Direct) | View |
| 2022-08-25 Exercise | 2022-08-29 9:18 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 4,127 | $0 | 89,505 (Direct) | View |
| 2022-08-25 Exercise | 2022-08-29 9:16 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director | 9,034 | $0 | 144,547 (Direct) | View |
| 2022-08-25 Exercise | 2022-08-29 9:14 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 6,889 | $0 | 158,153 (Direct) | View |
| 2022-08-25 Exercise | 2022-08-29 9:11 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO | 25,219 | $0 | 908,778 (Direct) | View |
| 2022-08-10 Option Award | 2022-08-11 7:01 pm | N/A 2032-08-10 | Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director | 30,282 | $0 | 30,282 (Direct) | View |
| 2022-08-10 Option Award | 2022-08-11 6:58 pm | N/A 2032-08-10 | Viracta Therapeutics Inc. | VIRX | Chung Jane Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:16 pm | N/A 2032-06-09 | Viracta Therapeutics Inc. | VIRX | Simon Barry J. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:13 pm | N/A 2032-06-09 | Viracta Therapeutics Inc. | VIRX | Rubino Stephen Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:10 pm | N/A 2032-06-09 | Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:07 pm | N/A 2032-06-09 | Viracta Therapeutics Inc. | VIRX | ONETTO NICOLE Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:04 pm | N/A 2032-06-09 | Viracta Therapeutics Inc. | VIRX | Murphy Samuel Lafayette Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:59 pm | N/A 2032-06-09 | Viracta Therapeutics Inc. | VIRX | Huang Michael Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:56 pm | N/A 2032-06-09 | Viracta Therapeutics Inc. | VIRX | DARCY THOMAS E Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:54 pm | N/A 2032-06-09 | Viracta Therapeutics Inc. | VIRX | Borellini Flavia Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:51 pm | N/A 2032-06-09 | Viracta Therapeutics Inc. | VIRX | Barlow Jane F Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-05-25 Exercise | 2022-05-27 5:34 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO | 25,219 | $0 | 922,157 (Direct) | View |
| 2022-05-25 Exercise | 2022-05-27 5:32 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 4,127 | $0 | 91,695 (Direct) | View |
| 2022-05-25 Exercise | 2022-05-27 5:30 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director | 9,034 | $0 | 144,547 (Direct) | View |
| 2022-05-25 Exercise | 2022-05-27 5:27 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 6,889 | $0 | 161,808 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:35 pm | N/A 2032-03-17 | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 195,000 | $0 | 195,000 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:34 pm | N/A 2032-03-17 | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:32 pm | N/A 2032-03-17 | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO | 412,500 | $0 | 412,500 (Direct) | View |
| 2022-02-25 Exercise | 2022-03-01 9:13 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO | 25,219 | $0 | 935,319 (Direct) | View |
| 2022-02-25 Exercise | 2022-03-01 9:12 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 4,127 | $0 | 93,849 (Direct) | View |
| 2022-02-25 Exercise | 2022-03-01 9:11 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director | 9,034 | $0 | 144,547 (Direct) | View |
| 2022-02-25 Exercise | 2022-03-01 9:10 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 6,889 | $0 | 165,404 (Direct) | View |
| 2021-12-29 Exercise | 2021-12-30 6:47 pm | N/A 2029-02-13 | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO | 7,000 | $0 | 657,688 (Direct) | View |
| 2021-12-29 Exercise | 2021-12-30 6:47 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO | 7,000 | $0.9 | 657,688 (Direct) | View |
| 2021-11-25 Exercise | 2021-11-29 7:51 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director | 18,068 | $0 | 144,547 (Direct) | View |
| 2021-11-25 Exercise | 2021-11-29 7:50 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 8,254 | $0 | 96,244 (Direct) | View |
| 2021-11-25 Exercise | 2021-11-29 7:48 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 13,777 | $0 | 169,402 (Direct) | View |
| 2021-11-25 Exercise | 2021-11-29 7:46 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO | 50,437 | $0 | 942,954 (Direct) | View |
| 2021-09-28 Exercise | 2021-09-29 6:04 pm | N/A 2029-07-30 | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 10,000 | $0 | 155,577 (Direct) | View |
| 2021-09-28 Exercise | 2021-09-29 6:04 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 10,000 | $0.9 | 155,577 (Direct) | View |